These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 11852102)
21. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. Evdokiou A; Bouralexis S; Atkins GJ; Chai F; Hay S; Clayer M; Findlay DM Int J Cancer; 2002 Jun; 99(4):491-504. PubMed ID: 11992538 [TBL] [Abstract][Full Text] [Related]
22. Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells. Song IS; Kim SU; Oh NS; Kim J; Yu DY; Huang SM; Kim JM; Lee DS; Kim NS Carcinogenesis; 2009 Jul; 30(7):1106-14. PubMed ID: 19406930 [TBL] [Abstract][Full Text] [Related]
23. Modulation of ROS/MAPK signaling pathways by okadaic acid leads to cell death via, mitochondrial mediated caspase-dependent mechanism. Ravindran J; Gupta N; Agrawal M; Bala Bhaskar AS; Lakshmana Rao PV Apoptosis; 2011 Feb; 16(2):145-61. PubMed ID: 21082355 [TBL] [Abstract][Full Text] [Related]
24. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL). Pawlowski JE; Nesterov A; Scheinman RI; Johnson TR; Kraft AS Anticancer Res; 2000; 20(6B):4243-55. PubMed ID: 11205254 [TBL] [Abstract][Full Text] [Related]
25. p38 mitogen-activated protein kinase is a key regulator of 5-phenylselenyl- and 5-methylselenyl-methyl-2'-deoxyuridine-induced apoptosis in human HL-60 cells. Kim BM; Lee KH; Hong IS; Hong SH Biochem Biophys Res Commun; 2012 Jan; 417(1):237-44. PubMed ID: 22142847 [TBL] [Abstract][Full Text] [Related]
26. Tumour necrosis factor-induced activation of c-Jun N-terminal kinase is sensitive to caspase-dependent modulation while activation of mitogen-activated protein kinase (MAPK) or p38 MAPK is not. Mohamed AA; Jupp OJ; Anderson HM; Littlejohn AF; Vandenabeele P; MacEwan DJ Biochem J; 2002 Aug; 366(Pt 1):145-55. PubMed ID: 11996667 [TBL] [Abstract][Full Text] [Related]
27. p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L). Grethe S; Ares MP; Andersson T; Pörn-Ares MI Exp Cell Res; 2004 Aug; 298(2):632-42. PubMed ID: 15265709 [TBL] [Abstract][Full Text] [Related]
28. TL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells. Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease. Yue TL; Ni J; Romanic AM; Gu JL; Keller P; Wang C; Kumar S; Yu GL; Hart TK; Wang X; Xia Z; DeWolf WE; Feuerstein GZ J Biol Chem; 1999 Jan; 274(3):1479-86. PubMed ID: 9880523 [TBL] [Abstract][Full Text] [Related]
29. Protective effects of estradiol on TRAIL-induced apoptosis in a human oligodendrocytic cell line: evidence for multiple sites of interactions. Cantarella G; Risuglia N; Lombardo G; Lempereur L; Nicoletti F; Memo M; Bernardini R Cell Death Differ; 2004 May; 11(5):503-11. PubMed ID: 14739940 [TBL] [Abstract][Full Text] [Related]
30. Valproic acid, an antiepileptic drug with histone deacetylase inhibitory activity, potentiates the cytotoxic effect of Apo2L/TRAIL on cultured thoracic cancer cells through mitochondria-dependent caspase activation. Ziauddin MF; Yeow WS; Maxhimer JB; Baras A; Chua A; Reddy RM; Tsai W; Cole GW; Schrump DS; Nguyen DM Neoplasia; 2006 Jun; 8(6):446-57. PubMed ID: 16820090 [TBL] [Abstract][Full Text] [Related]
31. Blockade of transforming growth factor-beta-activated kinase 1 activity enhances TRAIL-induced apoptosis through activation of a caspase cascade. Choo MK; Kawasaki N; Singhirunnusorn P; Koizumi K; Sato S; Akira S; Saiki I; Sakurai H Mol Cancer Ther; 2006 Dec; 5(12):2970-6. PubMed ID: 17172402 [TBL] [Abstract][Full Text] [Related]
32. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance. Ng CP; Zisman A; Bonavida B Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140 [TBL] [Abstract][Full Text] [Related]
33. p38 MAP kinase and ERK play an important role in nitric oxide-induced apoptosis of the mouse embryonic stem cells. Lee JH; Lee SW; Choi SH; Kim SH; Kim WJ; Jung JY Toxicol In Vitro; 2013 Feb; 27(1):492-8. PubMed ID: 22878015 [TBL] [Abstract][Full Text] [Related]
34. The natural phenolic peperobtusin A induces apoptosis of lymphoma U937 cells via the Caspase dependent and p38 MAPK signaling pathways. Shi L; Qin H; Jin X; Yang X; Lu X; Wang H; Wang R; Yu D; Feng B Biomed Pharmacother; 2018 Jun; 102():772-781. PubMed ID: 29604597 [TBL] [Abstract][Full Text] [Related]
35. Synergetic activation of p38 mitogen-activated protein kinase and caspase-3-like proteases for execution of calyculin A-induced apoptosis but not N-methyl-d-aspartate-induced necrosis in mouse cortical neurons. Ko HW; Han KS; Kim EY; Ryu BR; Yoon WJ; Jung YK; Kim SU; Gwag BJ J Neurochem; 2000 Jun; 74(6):2455-61. PubMed ID: 10820206 [TBL] [Abstract][Full Text] [Related]
36. Involvement of p38 MAP kinase during iron chelator-mediated apoptotic cell death. Kim BS; Yoon KH; Oh HM; Choi EY; Kim SW; Han WC; Kim EA; Choi SC; Kim TH; Yun KJ; Kim EC; Lyou JH; Nah YH; Chung HT; Cha YN; Jun CD Cell Immunol; 2002 Dec; 220(2):96-106. PubMed ID: 12657244 [TBL] [Abstract][Full Text] [Related]
37. Cleavage of mitogen-activated protein kinases in human neutrophils undergoing apoptosis: role in decreased responsiveness to inflammatory cytokines. Suzuki K; Hasegawa T; Sakamoto C; Zhou YM; Hato F; Hino M; Tatsumi N; Kitagawa S J Immunol; 2001 Jan; 166(2):1185-92. PubMed ID: 11145700 [TBL] [Abstract][Full Text] [Related]
39. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment]. Zhang YX; Kong CZ Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842 [TBL] [Abstract][Full Text] [Related]
40. Acetaminophen induces apoptosis of C6 glioma cells by activating the c-Jun NH(2)-terminal protein kinase-related cell death pathway. Bae MA; Pie JE; Song BJ Mol Pharmacol; 2001 Oct; 60(4):847-56. PubMed ID: 11562448 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]